Clinical Trials

NIH Establishes National Research Study Recruitment Registry
A nationwide registry has been created to match volunteers with researchers. ResearchMatch.org is a secure, user-friendly web site that is complementary to Clinicaltrials.gov. ResearchMatch will match individuals in the US with researchers who are approved to recruit volunteers. Researchers affiliated with participating Clinical and Translational Science Awards (CTSAs) institutions may use the web site during the first year of the project.

Clinical trials

Clinical trial participation is an individual, and important, decision. Clinical trials are designed to test new medications in people. Clinical trials may involve a placebo group (inactive ‘medicine’) to see if the new medication offers an advantage over current standard treatment. Some trials are ‘open label’, in which all participants receive active medications or experimental treatment.

There are many advantages to participating in clinical trials. Participants in clinical trials at a minimum receive current standard care for their disease from medical teams experienced with the disease. Clinical trials also offer the opportunity to try a new medication long before it is approved by the Food and Drug Administration.

If you choose to participate in a clinical trial, you have the right to understand fully what is expected of you, what the trial will involve and the potential risks to your health. You also have the right to withdraw your consent to participate at any time. Learn more about clinical trials, including those listed on this page, at www.clinicaltrials.gov.

The clinical trials listed here were verified as open and enrolling at the time the post was made, and are monitored periodically to ensure that the trial is still accepting participants. If a trial is no longer accepting patients, APFED may not be notified. If you find that registration has closed for a trial that is still listed on this page, please notify mail@apfed.org.

Trials That May be of Interest to Our Members
Updated 1/23/15

Eosinophilic Colitis (EC)

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

A Double-blind, Randomised, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment ofEosinophilic Granulomatosis With Polyangiitis in Subjects Receiving Standard of Care Therapy

Study Reference: NCT02020889
Location: Please view the link below for the complete list of locations.Learn more